federal_register: 2016-12654

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2016-12654 Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction Notice The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Tuesday, May 10, 2016 (81 FR 28876). The document announced a public workshop entitled "Clinical Trial Design Considerations for Malaria Drug Development." The document was published with the incorrect title and incorrect Internet address in the Transcripts section. This document corrects those errors. 2016-05-31 2016 5 https://www.federalregister.gov/documents/2016/05/31/2016-12654/clinical-trial-design-considerations-for-malaria-drug-development-notice-of-public-workshop https://www.govinfo.gov/content/pkg/FR-2016-05-31/pdf/2016-12654.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Tuesday, May 10, 2016 (81 FR 28876). The document announced a public workshop entitled "Clinical Trial Design Considerations for Malaria Drug...  

Links from other tables